这是描述信息
aoyang aoyang
/
/
Industry News
Analysis on the situation of pharmaceutical foreign trade in the first quarter of 2011
Analysis
In the first quarter of this year, the world economy continued to recover, the global pharmaceutical trade was heating up, the domestic pharmaceutical market developed rapidly, and the import demand for high-end pharmaceutical products increased sharply. my country's pharmaceutical trade achieved rapid growth in phases. The pharmaceutical foreign trade import and export volume reached 16.224 billion U.S. dollars, a year-on-year increase. An increase of 41.07%, of which exports were 10.119 billion U.S. dollars, an increase of 38.13% year-on-year, and imports were 6.105 billion U.S. dollars, an increase of 46.23% year-on-year. The growth rates of imports and exports were better than expected.
See more information
In the first quarter of this year, the world economy continued to recover, the global pharmaceutical trade was heating up, the domestic pharmaceutical market developed rapidly, and the import demand for high-end pharmaceutical products increased sharply. my country's pharmaceutical trade achieved rapid growth in phases. The pharmaceutical foreign trade import and export volume reached 16.224 billion U.S. dollars, a year-on-year increase. An increase of 41.07%, of which exports were 10.119 billion U.S. dollars, an increase of 38.13% year-on-year, and imports were 6.105 billion U.S. dollars, an increase of 46.23% year-on-year. The growth rates of imports and exports were better than expected.
The United States Pharmacopeia publishes new heparin quality standards
The
In order to ensure the quality of heparin products and prevent potential contamination, the US Pharmacopoeia Commission decided to adopt new production control methods for heparin. The revised U.S. Pharmacopoeia standard has been announced and effective on October 1.
See more information
In order to ensure the quality of heparin products and prevent potential contamination, the US Pharmacopoeia Commission decided to adopt new production control methods for heparin. The revised U.S. Pharmacopoeia standard has been announced and effective on October 1.
Why the price of heparin sodium will reverse the rise
Why
Since the 1990s, mad cow diseases in European and American countries have been one after another. In order to ensure the quality and safety of heparin sodium products, European and American pharmaceutical companies have completely stopped purchasing heparin sodium extracted from European and American beef intestines and beef lungs. This objectively promotes Chinese pigs. The price of small intestine heparin is stable and on the rise. At the end of March 2010, the global H1n1 influenza broke out in Mexico and the southwestern United States. The international market has erected a barrier to Mexico’s heparin exports. With the loss of Mexico’s heparin market share, a large number of heparin purchase orders have been concentrated in China. Suddenly, the demand for heparin has increased sharply, and major heparin export companies have also increased their purchase prices in order to obtain more heparin supplies.
See more information
Since the 1990s, mad cow diseases in European and American countries have been one after another. In order to ensure the quality and safety of heparin sodium products, European and American pharmaceutical companies have completely stopped purchasing heparin sodium extracted from European and American beef intestines and beef lungs. This objectively promotes Chinese pigs. The price of small intestine heparin is stable and on the rise. At the end of March 2010, the global H1n1 influenza broke out in Mexico and the southwestern United States. The international market has erected a barrier to Mexico’s heparin exports. With the loss of Mexico’s heparin market share, a large number of heparin purchase orders have been concentrated in China. Suddenly, the demand for heparin has increased sharply, and major heparin export companies have also increased their purchase prices in order to obtain more heparin supplies.
Previous page
1
2

Contact Us

 

Address: Building B6-2, No. 9, Weidi Road, Xianlin University Town, Xianlin Subdistrict, Qixia District, Nanjing City, China

Sales mailbox:sales@syngenebio.com

After-sale mailbox:service@syngenebio.com

公众号二维码

Scan and follow us